FDA Clearance Tracker · P020024-S067
Amplatzer Piccolo Occluder
Last checked: Nov 20, 2026Latest source record: Mar 27, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Mar 27, 2023
Approved
Time to decision
143 days
Received Nov 4, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P020024-S067
- Device name
- Amplatzer Piccolo Occluder
- Applicant
- ABBOTT MEDICAL
- Applicant location
- St. Paul, MN
- Received
- Nov 4, 2022
- Decided
- Mar 27, 2023
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Labeling Change - PAS
- Original approval
- P020024
Device type
- Device type
- OCCLUDER, PATENT DUCTUS, ARTERIOSUS (MAE)
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
Approval for modifications to the Instructions for Use to include the 3-year follow up data on patients enrolled in the ADO II AS Clinical Study (IDE and Continued Access Cohorts).
Source documents
Other decisions for ABBOTT MEDICAL
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P260019 · Decided Oct 27, 2026 · 180 days after receipt
Device type: Para-device leak occluder (SJT) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.